Modica, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 789
EU - Europa 330
AS - Asia 80
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.239
Nazione #
US - Stati Uniti d'America 783
IT - Italia 159
NL - Olanda 67
CN - Cina 56
CI - Costa d'Avorio 37
DE - Germania 21
UA - Ucraina 17
SE - Svezia 16
IE - Irlanda 14
VN - Vietnam 13
FI - Finlandia 12
FR - Francia 10
GB - Regno Unito 10
CA - Canada 6
IN - India 6
HK - Hong Kong 2
AR - Argentina 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
NP - Nepal 1
PL - Polonia 1
RU - Federazione Russa 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.239
Città #
Chandler 185
Ashburn 124
Amsterdam 65
Naples 52
Millbury 23
Beijing 21
Des Moines 20
Napoli 19
Seattle 18
Boston 15
Jacksonville 15
Lawrence 15
Nanjing 14
Princeton 13
Dong Ket 12
Washington 12
Rome 11
Wilmington 11
Kronberg 8
Milan 7
Nanchang 7
Houston 6
Ottawa 5
Paris 5
Dublin 4
Helsinki 4
Pune 4
Boardman 3
Buffalo 3
Hebei 3
Lappeenranta 3
London 3
Philadelphia 3
Woodbridge 3
Ann Arbor 2
Bari 2
Bicester 2
Cagliari 2
Fairfield 2
Hanover 2
Hong Kong 2
Marcianise 2
Messina 2
Mosciano Sant'Angelo 2
Piano Di Sorrento 2
Portici 2
Pozzuoli 2
Redwood City 2
Riva del Garda 2
Scafati 2
Shenyang 2
Solaro 2
Tappahannock 2
Torre Del Greco 2
Afragola 1
Arienzo 1
Atlanta 1
Boydton 1
Brindisi 1
Buenos Aires 1
Chisinau 1
Council Bluffs 1
Edinburgh 1
Frankfurt am Main 1
Freiburg im Breisgau 1
Garden City 1
Giugliano In Campania 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Jiaxing 1
Johannesburg 1
Kagoya 1
Kathmandu 1
Kunming 1
Köln 1
Landshut 1
Lembach 1
Marzano di Nola 1
Mcallen 1
Mumbai 1
New Delhi 1
Norwich 1
Nuremberg 1
Portland 1
San Jose 1
Santa Clara 1
Shenzhen 1
Singapore 1
Spresiano 1
Staten Island 1
Taizhou 1
Tianjin 1
Torino 1
Uhlingen-Birkendorf 1
Zhengzhou 1
Totale 798
Nome #
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 59
Hepatic arterial embolization in patients with neuroendocrine tumors. 55
GLP-1: benefits beyond pancreas. 53
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 45
Pituitary function and morphology in Fabry disease. 41
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 39
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 38
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 38
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 37
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 37
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 36
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 36
Nutrition and neuroendocrine tumors: An update of the literature. 35
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 35
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 34
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 33
Open issues on G3 neuroendocrine neoplasms: Back to the future 32
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 30
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 30
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 30
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 29
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 29
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 29
The safety of available treatments options for neuroendocrine tumors 27
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 26
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 25
Erratum to: GLP-1: Benefits beyond pancreas 23
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 19
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 18
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 17
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 17
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 17
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 15
A rare rarity: Neuroendocrine tumor of the esophagus 13
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 13
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 12
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 12
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 12
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 12
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 12
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 12
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 11
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 11
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 10
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 9
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 8
Prognostic significance of laterality in lung neuroendocrine tumors 8
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 8
Corrigendum to: Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 8
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 7
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 7
Carcinoma showing thymus-like differentiation (CASTLE): a case report 7
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 7
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) 7
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 7
PRRT: identikit of the perfect patient 6
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 6
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 6
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 6
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 5
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 5
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 4
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 4
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 4
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 3
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays 2
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms 2
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? 2
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 2
Parathyroid diseases and metabolic syndrome 2
Neuroendocrine Tumors and Immune System 2
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC) 2
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 2
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 2
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 1
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia 1
Immune checkpoint inhibitors in cancer therapy: The leading role of the endocrinologist 1
Totale 1.347
Categoria #
all - tutte 6.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 2 3 2 4
2019/202065 20 0 3 1 6 3 0 2 1 13 12 4
2020/202191 0 5 16 10 9 13 9 1 7 2 6 13
2021/2022215 2 0 25 3 5 14 1 6 17 16 64 62
2022/2023499 31 57 14 39 51 41 56 33 50 84 41 2
2023/2024398 20 66 53 49 40 67 17 84 2 0 0 0
Totale 1.347